Stockscreener 앱 받기
1.92
1.03%
-0.02
전일 마감가:
$1.94
열려 있는:
$1.94
하루 거래량:
133.52K
Relative Volume:
1.06
시가총액:
$81.35M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-1.8286
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
+1.59%
1개월 성능:
-4.48%
6개월 성능:
-20.33%
1년 성능:
-33.79%
1일 변동 폭
$1.875
$1.9691
1주일 범위
$1.86
$2.00
52주 변동 폭
$1.59
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.92 | 82.20M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
126.71 | 220.59B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.48 | 137.79B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.58 | 134.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.30 | 125.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.84 | 49.51B | 5.88B | 1.34B | 799.60M | 2.3489 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Momentum & Entry Point Confirmation Signals - Улправда
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer? - TipRanks
Aug Selloffs: How InspireMD Inc stock compares to growth peers2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Head-To-Head Review: Biotricity (NASDAQ:BTCY) versus InspireMD (NYSE:NSPR) - Defense World
Peter A. Soukas Joins InspireMD as Chief Medical Officer - Medical Product Outsourcing
Investment Report: Will InspireMD Inc stock gain from lower inflationWeekly Stock Analysis & Reliable Price Breakout Signals - moha.gov.vn
Total debt per share of InspireMD Inc. – MUN:II2 - TradingView
InspireMD Director Paul Stuka Acquires 10,130 Shares - TradingView
Dir Stuka Buys 10,130 ($18.7K) Of InspireMD Inc [NSPR] - TradingView — Track All Markets
Can InspireMD Inc. (II2) stock survive global slowdownM&A Rumor & High Conviction Trade Alerts - Newser
Is InspireMD Inc. (II2) stock supported by strong fundamentalsWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
InspireMD (NSPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Financial Contrast: InspireMD (NYSE:NSPR) vs. Biostage (OTCMKTS:BSTG) - Defense World
Will InspireMD Inc. (II2) stock profit from fiscal stimulusWeekly Gains Report & Risk Managed Investment Entry Signals - BỘ NỘI VỤ
How InspireMD Inc. stock performs in rate cut cyclesTreasury Yields & Verified Swing Trading Watchlists - BỘ NỘI VỤ
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Yahoo Finance
InspireMD (NYSE:NSPR) Shares Up 2%Should You Buy? - MarketBeat
InspireMD announces publication of CREST-2 data in NEJM - MSN
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
InspireMD Celebrates Positive Outcomes from CREST-2 Study Supporting Carotid Stenting for Asymptomatic Patients - Quiver Quantitative
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - The Manila Times
Landmark CREST-2 Study Published in the New England Journal - GlobeNewswire
InspireMD announces inducement grants - Medical Buyer
InspireMD Reports Record Revenue Amid U.S. Launch - MSN
What analysts say about InspireMD Inc stockMarket Correction Analysis & Low Entry Cost Trading - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD (Nasdaq: NSPR) grants 122,054 inducement shares to eight new hires - Stock Titan
What catalysts could drive InspireMD Inc. stock higherEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Is InspireMD Inc. (II2) stock suitable for passive index fundsOil Prices & Capital Protection Trade Alerts - newser.com
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Why analysts remain bullish on InspireMD Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Applying sector rotation models to InspireMD Inc.Quarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
InspireMD (NASDAQ: NSPR) schedules fireside chat at Piper Sandler healthcare conference - Stock Titan
How InspireMD Inc. (II2) stock responds to job market shifts2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Applying chart zones and confluence areas to InspireMD Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Is InspireMD Inc. stock poised for growthPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
NSPR SEC FilingsInspiremd 10-K, 10-Q, 8-K Forms - Stock Titan
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
0.54%
자본화:
|
볼륨(24시간):